Remove Events Remove Individual Remove Patient-Centered Remove Patients
article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Study design and analysis This is a multiple-center retrospective real-world cohort study. Population Studied individuals with comorbidity of hypertension and type 2 diabetes.

article thumbnail

Patient Violence Travels Cross-Setting: From EMS to ED to Inpatient

Physician's Weekly

Research shows that patient violence spans care settings, starting in the out-of-hospital setting, continuing in the ED, and persisting into inpatient units. The analysis captured 206 violent out-of-hospital encounters, 868 violent ED encounters, and 3,561 violent non-ED hospital encounters involving 2,251 unique patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Natural History of Asymptomatic Renal Stones Before RC

Physician's Weekly

Researchers conducted a retrospective study to examine the outcomes and natural history of asymptomatic renal stones managed by observation following RC and UD. They reviewed individuals referred for RC and UD between 2015 and 2023 at a single center. The mean stone burden was 4.5 mm (SD ± 2.75).

article thumbnail

Podcast: AI, innovation, and value-based care in medicine

Permanente Medicine

Khang Nguyen, MD, chief transformation officer of the Southern California Permanente Medical Group, discusses how AI can increase clinicians’ joy in medicine and improve patient outcomes with Chris Grant, chief operating offer and executive vice president of Kaiser Permanente, The Permanente Federation, and host of the Permanente Medicine Podcast.

article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

FDA Law

Instead, FDA recommended that sponsors “limit the use of a DMC” to clinical studies in which safety concerns may be unusually high, such as studies that compare rates of mortality or major morbidity or involving a potentially fragile or high-risk population, or large, multi-center studies of long duration.

Clinic 105
article thumbnail

Our Anxiety Epidemic: How to Stop Fearing the Future

Priority Physicians

In fact, for people who’ve experienced terrifying or anxiety-inducing events, therapists apply eye movement desensitization and reprocessing, or EMDR, a technique that mimics the patient’s REM-sleep eye movements, allowing them to “relive” and discuss the incident with decreased anxiety.) He completed his residency at St.

article thumbnail

Rheumatology Board Meeting Summary | Spring 2025

ABIM

Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations. ABIM does not contact individual programs with a lower pass rate to initiate changes to the program. ACR also maintains a legislative action center for members to access advocacy updates.